Search Results

Site Search

Mayo Clinic Laboratories and Amprion announce collaboration to advance neurodegenerative disease diagnostics - Insights

Mayo Clinic Laboratories and Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the...

Testing Archives - Page 24 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Newsroom - Insights

The newsroom features stories of Mayo Clinic Laboratories and its experts in the news. For media inquiries and expert interviews, contact the Media Relations Newsroom at newsbureau@mayo.edu, attention: Mayo Clinic Laboratories.

Drug class testing - Insights

Check out Mayo Clinic Laboratories’ full menu of testing for individual drug classes, including benzodiazepines, stimulants, opioids, alcohol, and more.

Testing Archives - Page 22 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Testing Archives - Page 23 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

New tests launched in February - Insights

In February 2023, Mayo Clinic Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New tests launched in February - Insights

In February 2022, Mayo Clinic Laboratories announced fourteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Testing Archives - Page 5 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Testing Archives - Page 6 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...